Stock NLSP NLS PHARMACEUTICS AG
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NLS Pharmaceutics AG

Equities

NLSP

CH0523961370

Market Closed - Nasdaq
Other stock markets
 21:30:00 25/06/2024 BST 		5-day change 1st Jan Change
0.1684 USD -5.61% Intraday chart for NLS Pharmaceutics AG -37.65% -71.45%
06-11 NLS Pharmaceutics AG Publication of New Patent Application for Next-Gen Dual Non-Sulfonamide Orexin Receptor Agonists CI
06-11 NLS Pharmaceutics Says New Patent Application for Dual Non-Sulfonamide Orexin Receptor Agonists Published by WIPO MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NLS PHARMACEUTICS AG Stock NLS Pharmaceutics AG
 7.16M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 52.5B -
LONZA GROUP AG Stock Lonza Group AG
 39.31B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 39.01B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 28.2B -
CELLTRION, INC. Stock Celltrion, Inc.
 26.57B
  1. Stock Market
  2. Equities
  3. NLSP Stock
  4. Charts NLS Pharmaceutics AG
  5. Sector Chart